Dr. Robin L. Smith founded The Stem for Life Foundation and has held the position of President and Chairman of the Board of Directors of since 2007. Dr Smith also served as Chairman of the Board of Directors of Caladrius Biosciences (formerly NeoStem) after leading the company as Chief Executive Officer and Chairman of the company from 2006 to 2015, where she positioned the company as a leader in the emerging cellular therapy industry. She currently serves on the Board of Directors of Signal Genetics (NASDAQ: SGNL), BioXcel and MyND Analytics. She also serves on the Board of Directors of the Science and Faith STOQ Foundation in Rome. She served on the Board of Trustees of the NYU Langone Medical Center and is past Chairman of the Board of Directors for the New York University Hospital for Joint Diseases. as well as on the Capital Formation Committee of the Alliance for Regenerative Medicine.

Dr. Smith earned her M.D. from Yale University and her M.B.A. from the Wharton School of Business.